Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiurong Cai

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cells|January 8, 2023
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?Xiurong Cai, Adrien Guillot, Hanyang Liu
Nature Cancer|July 18, 2025
Clonal hematopoiesis in myeloid malignancies and solid tumorsXiurong Cai, Robert L Bowman, Jennifer J Trowbridge
Frontiers in Immunology|June 1, 2023
Cholangiokines: undervalued modulators in the hepatic microenvironmentXiurong Cai, Frank Tacke, Adrien Guillot, et al.
Cancer Cell International|June 20, 2024
CDK4/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicityXiurong Cai, Guo Yin, Shuai Chen, et al.
Bioengineered|May 6, 2022
The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological dataShuai Chen, Xiurong Cai, Yu Liu, et al.
Journal of Cellular Physiology|July 16, 2020
circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progressionChangchang Jia, Zhicheng Yao, Zexiao Lin, et al.
International Journal of Biological Sciences|September 9, 2024
Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomyShuai Chen, Qinghe Zeng, Xiurong Cai, et al.
Journal of Cancer|January 2, 2018
Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer TherapiesXiurong Cai, Zhanhong Chen, Jie Chen, et al.
Blood|November 24, 2020
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasMaurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, et al.
Nature Communications|April 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesisKira A Young, Mohsen Hosseini, Jayna J Mistry, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cells|January 8, 2023
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?Xiurong Cai, Adrien Guillot, Hanyang Liu
Nature Cancer|July 18, 2025
Clonal hematopoiesis in myeloid malignancies and solid tumorsXiurong Cai, Robert L Bowman, Jennifer J Trowbridge
Frontiers in Immunology|June 1, 2023
Cholangiokines: undervalued modulators in the hepatic microenvironmentXiurong Cai, Frank Tacke, Adrien Guillot, et al.
Cancer Cell International|June 20, 2024
CDK4/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicityXiurong Cai, Guo Yin, Shuai Chen, et al.
Bioengineered|May 6, 2022
The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological dataShuai Chen, Xiurong Cai, Yu Liu, et al.
Journal of Cellular Physiology|July 16, 2020
circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progressionChangchang Jia, Zhicheng Yao, Zexiao Lin, et al.
International Journal of Biological Sciences|September 9, 2024
Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomyShuai Chen, Qinghe Zeng, Xiurong Cai, et al.
Journal of Cancer|January 2, 2018
Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer TherapiesXiurong Cai, Zhanhong Chen, Jie Chen, et al.
Blood|November 24, 2020
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasMaurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, et al.
Nature Communications|April 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesisKira A Young, Mohsen Hosseini, Jayna J Mistry, et al.
Pageof 2